Institutional Ownership
Liminatus Pharma Inc.
CUSIP 53271X116*W EXP 04/30/203LIMNWQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
21
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Aristeia Capital, L.L.C. | 319.5K | $15.7K |
| 2 | Linden Advisors LP | 268.2K | $13.1K |
| 3 | Saba Capital Management, L.P. | 233.8K | $11.5K |
| 4 | Polar Asset Management Partners Inc. | 122.7K | $6.0K |
| 5 | Moore Capital Management, LP | 125.0K | $5.0K |
| 6 | Mmcap International Inc. Spc | 111.7K | $4.5K |
| 7 | D. E. Shaw & Co., Inc. | 83.4K | $3.3K |
| 8 | Blue Owl Capital Holdings LP | 50.0K | $2.0K |
| 9 | Periscope Capital Inc. | 47.5K | $1.9K |
| 10 | Wolverine Asset Management LLC | 39.4K | $1.6K |